Neoplasms: all 9,610 studies
Page 16 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)RecruitingNCT06153147
- Development of New Diagnostic Tools in Capsule EndoscopyRecruitingNCT06152289
- An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After OophorectomyRecruitingNCT06151028
- Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological MalignanciesRecruitingNCT06150469Not applicable
- Personalized KSX01-TCRT in Patients With Advanced Solid TumorsRecruitingNCT06150365Early Phase 1
- A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsRecruitingNCT06150157Phase 1
- Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.Not yet recruitingNCT06144723Phase 1/2
- First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid TumorsNot yet recruitingNCT06134531Phase 1
- Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid TumorsRecruitingNCT06132503Phase 1
- A Study of Simmitinib Plus SG001 in Advanced Solid TumorsNot yet recruitingNCT06132217Phase 1/2
- Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant TumorsNot yet recruitingNCT06131216Phase 1
- Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral BreastRecruitingNCT06129747Phase 2
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRecruitingNCT06128551Phase 1/2
- Anatomical-Clinical Base of Adenocarcinoma PancreaticRecruitingNCT06128343
- Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation TherapyRecruitingNCT06127654Phase 3
- TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCTRecruitingNCT06125483Not applicable
- Local Cecal Cancer - Optimization of Surgical TreatmentRecruitingNCT06121089Not applicable
- Effect of Guided Imagery on Chemotherapy-related Nausea and VomitingRecruitingNCT06120764Not applicable
- En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.RecruitingNCT06120426
- Precision Cancer Therapy in Rare CancersRecruitingNCT06119789Phase 2
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRecruitingNCT06119581Phase 3
- The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)RecruitingNCT06118723
- A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid TumorsRecruitingNCT06117566Phase 1/2
- A Study of WX390 in Patients With Advanced Solid TumorsRecruitingNCT06117540Phase 2
- Reducing Metabolic Dysregulation in DyadsRecruitingNCT06117241Not applicable
- Immune Profiling for Cancer Immunotherapy ResponseRecruitingNCT06116032
- EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast CancerRecruitingNCT06115486Not applicable
- The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)Not yet recruitingNCT06112041Phase 2
- CT-guided Pudendal Nerve Cryoneurolysis for Palliation of Malignancy-induced Pelvic PainNot yet recruitingNCT06110065
- Prevelance Of Cutaneous Disorders Among Patients With Heamatologic MalignanciesNot yet recruitingNCT06108622
- Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular LymphomaRecruitingNCT06108232Phase 2
- Biennial CEM in Women With a Personal History of Breast CancerRecruitingNCT06105749Not applicable
- A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid TumorsRecruitingNCT06101082Phase 1
- Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot StudyRecruitingNCT06098404
- Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRASRecruitingNCT06096974Phase 1
- Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCCRecruitingNCT06096038Phase 1
- An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid TumorsRecruitingNCT06094556Phase 1
- A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid TumorsNot yet recruitingNCT06092268Phase 1/2
- UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.RecruitingNCT06092047Early Phase 1
- Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer PatientsNot yet recruitingNCT06090513
- A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer AgentsRecruitingNCT06090266Phase 1/2
- Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid (BLADE)Not yet recruitingNCT06090214Not applicable
- Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid TumorsRecruitingNCT06086522Phase 1
- Combination Therapy for Cancer Related Fatigue in Patients With Metastatic CancersRecruitingNCT06085716Phase 2/3
- 68Ga-TCR-FAPI PET/CT in Patients With Various Types of CancerRecruitingNCT06084767Not applicable
- Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients with CLDN18.2-positive Advanced Solid TumorsRecruitingNCT06084286Phase 1
- EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for CancerRecruitingNCT06083324
- αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)RecruitingNCT06082947Not applicable
- A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor PatientsNot yet recruitingNCT06082570Phase 1/2
- A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor PatientsNot yet recruitingNCT06082557Phase 1/2
- FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their CarersNot yet recruitingNCT06082128Not applicable
- The Efficacy and Safety of IBI363 in Solid TumorsRecruitingNCT06081907Phase 1/2
- The Application of Novel Oncolytic Virus in Late Stage Solid TumorsRecruitingNCT06080984Phase 1
- A Study of YL-17231 in Patients With Advanced Solid TumorsRecruitingNCT06078800Phase 1
- PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid TumorsNot yet recruitingNCT06078670Phase 1/2
- Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating AgentRecruitingNCT06075849Phase 1
- Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid TumorsRecruitingNCT06072989Phase 1
- Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.RecruitingNCT06072612Phase 3
- A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate CancerRecruitingNCT06067841Phase 1
- Robotic Right Hemicolectomy Versus Laparoscopic Right HemicolectomyNot yet recruitingNCT06067620Not applicable
- Hepatic Small Vessel NeoplasmNot yet recruitingNCT06067035
- PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUMNot yet recruitingNCT06066255Phase 2
- A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid TumorsRecruitingNCT06063681Phase 1
- Cryopreservation of Prepubertal Testicular Tissue for Preservation of Fertility in Young Boys With CancerRecruitingNCT06063551Not applicable
- Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant TumorsRecruitingNCT06059508Phase 1
- A Study of HB0045 Injection in Patients With Advanced Solid TumorsRecruitingNCT06056323Phase 1/2
- Multisite Implementation of COMPRENDORecruitingNCT06055296Not applicable
- XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)RecruitingNCT06055179Not applicable
- Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid TumorsRecruitingNCT06054932Phase 1
- SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS TechnologyRecruitingNCT06053086Not applicable
- NV-001 in the Treatment of Advanced Solid TumorsRecruitingNCT06051760Phase 1
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionRecruitingNCT06051695Phase 1/2
- The Gut Microbiome and Immunotherapy Response in Solid CancersRecruitingNCT06050733
- Factors Affecting the Results of Treatment of Patients With Colorectal CancerRecruitingNCT06050447
- A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung CancerRecruitingNCT06047860Phase 2
- A Study of QL1706H in Patients With Advanced Solid TumorsNot yet recruitingNCT06047431Phase 1
- A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell MalignanciesRecruitingNCT06045910Phase 1/2
- Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)RecruitingNCT06044441Not applicable
- Outcome Evaluation After Fertility PreservationRecruitingNCT06043609
- Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological MalignanciesRecruitingNCT06041815
- A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid TumorsNot yet recruitingNCT06041035Phase 1/2
- Effectiveness of a Cancer Exercise ProgramEnrolling by invitationNCT06039488Not applicable
- A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid TumorsRecruitingNCT06038396Phase 1/2
- Cannabis Use and Outcomes in Black and White Patients With CancerRecruitingNCT06037681
- A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid TumorsRecruitingNCT06037317Phase 1
- Study of VIP943 in Subjects With Advanced CD123+ Hematologic MalignanciesRecruitingNCT06034275Phase 1
- Endoscopic Submucosal Dissection RegistryRecruitingNCT06033976
- Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11)RecruitingNCT06032845Phase 2
- Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological ImmunotherapieRecruitingNCT06031233Phase 4
- MyCustom:Prospective Master Protocol Trial on Precision Medicine Treatment for Refractory Solid TumorsRecruitingNCT06030869
- 99mTc-CNDG Injection in the Diagnosis of Malignant TumorsRecruitingNCT06030817Not applicable
- Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction CancerRecruitingNCT06028737Phase 2/3
- A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)RecruitingNCT06028724
- Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6RecruitingNCT06028672Not applicable
- A Study of Bio-008 in Subjects With Advanced or Metastatic Solid TumoursRecruitingNCT06027346Phase 1
- Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System NeoplasmsRecruitingNCT06026800Phase 1
- Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System NeoplasmsRecruitingNCT06026774Phase 1
- A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid TumorNot yet recruitingNCT06026501Phase 1/2
- MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic StrategiesNot yet recruitingNCT06022341Not applicable
- Nimotuzumab for EGFR-amplified Advanced Pan Solid TumorsRecruitingNCT06022276Not applicable